Focuses on the use of itraconazole and terbinafine therapy for toenail onychomycosis. Decline of the mycological cure rates for itraconazole; Exclusion of the cases of hepatotoxicity in the terbinafine package insert; Treatment of dermatophytosis by an fungicidal agent terbinafine.